Exelixis EXEL
NASDAQ EXEL
$58.24 +0.30 (+0.51%)
As of: Oct 2, 2026 · 1:52 PM EDT

Exelixis (EXEL) Net Equity Issued and Repurchased (2010 - 2026)

Updated

Exelixis (EXEL) reported Net Equity Issued and Repurchased of $15.44 million for Q2 2027, down 40.8% from $26.08 million a year earlier but up 106.6% from the prior quarter.

Analysis

Exelixis (EXEL) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

Over the twelve months ended Jul 3, 2026, Exelixis' Net Equity Issued and Repurchased came in at $34.34 million, down 55.0% year-over-year; for FY2026, it came in at $49.14 million, down 20.6% from FY2025.

  • Net Equity Issued and Repurchased has a five-year compound annual growth rate of 15.1% (FY2021 to FY2026).
  • By year, Net Equity Issued and Repurchased came in at $61.85 million in FY2025, $33.45 million in FY2023 (+40.0%) and $23.89 million in FY2022 (-1.7%).
  • Five-year quarterly Net Equity Issued and Repurchased spans a low of $3.55 million in Q3 2026 and a high of $26.08 million in Q2 2026.
  • Year over year, Net Equity Issued and Repurchased has now declined in each of the last four quarters, with an average decline of 17.0% over the last six quarters.
  • Per Business Quant data, the three quarters before Q2 2027 came in at $7.47 million (Q1 2027), $7.88 million (Q4 2026) and $3.55 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Exelixis 14.54 Bn 10.87 Bn 608.03 Mn 15.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 15.44 Mn
Apr 3, 2026 7.47 Mn
Jan 2, 2026 7.88 Mn
Oct 3, 2025 3.55 Mn
Jul 4, 2025 26.08 Mn
Apr 4, 2025 11.63 Mn
Jan 3, 2025 18.82 Mn
Sep 27, 2024 19.79 Mn
Jun 28, 2024 14.92 Mn
Mar 29, 2024 8.32 Mn
Dec 29, 2023 9.11 Mn
Sep 29, 2023 6.92 Mn
Jun 30, 2023 10.28 Mn
Mar 31, 2023 7.14 Mn
Dec 30, 2022 5.21 Mn
Sep 30, 2022 2.89 Mn
Jul 1, 2022 10.90 Mn
Apr 1, 2022 4.89 Mn
Dec 31, 2021 6.07 Mn
Oct 1, 2021 2.76 Mn
API Access

Exelixis Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EXEL&period=max&api_key=YOUR_API_KEY